Developers of serology tests for COVID-19 got additional guidance from the US Food and Drug Administration (FDA) on 17 March, as the agency issued a new emergency use authorization (EUA) template for the diagnostics and updated an existing one.
The agency has issued a total of nine EUA templates for molecular, antigen and serology/antibody tests as a way to show sponsors what information to include when submitting new applications....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?